These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36147476)

  • 1.
    Liu F; Bouznad N; Kaller M; Shi X; König J; Jaeckel S; Hermeking H
    Int J Biol Sci; 2022; 18(14):5415-5437. PubMed ID: 36147476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.
    Shi X; Kaller M; Rokavec M; Kirchner T; Horst D; Hermeking H
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):391-418. PubMed ID: 32304779
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Jiang L; Hermeking H
    Cancer Res; 2017 May; 77(10):2746-2758. PubMed ID: 28363996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
    Li H; Rokavec M; Jiang L; Horst D; Hermeking H
    Gastroenterology; 2017 Aug; 153(2):505-520. PubMed ID: 28435028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in HCT116 colorectal cancer cells: comprehensive characterization after exposure to 5-FU reveals EMT and autophagy as key processes regulated by miR-34.
    Huang Z; Kaller M; Hermeking H
    Cell Death Differ; 2023 Aug; 30(8):2017-2034. PubMed ID: 37488217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.
    Rokavec M; Öner MG; Li H; Jackstadt R; Jiang L; Lodygin D; Kaller M; Horst D; Ziegler PK; Schwitalla S; Slotta-Huspenina J; Bader FG; Greten FR; Hermeking H
    J Clin Invest; 2014 Apr; 124(4):1853-67. PubMed ID: 24642471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing.
    König J; Rokavec M; Öner-Ziegler MG; Fei Y; Hermeking H
    Cell Death Differ; 2024 Oct; ():. PubMed ID: 39425000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.
    Öner MG; Rokavec M; Kaller M; Bouznad N; Horst D; Kirchner T; Hermeking H
    Gastroenterology; 2018 Dec; 155(6):1868-1882. PubMed ID: 30099074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.
    Siemens H; Jackstadt R; Kaller M; Hermeking H
    Oncotarget; 2013 Sep; 4(9):1399-415. PubMed ID: 24009080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COUP‑TFII promotes epithelial‑mesenchymal transition by inhibiting miR‑34a expression in colorectal cancer.
    Bao Y; Lu Y; Feng W; Yu H; Guo H; Tao Y; Shi Q; Chen W; Wang X
    Int J Oncol; 2019 Apr; 54(4):1337-1344. PubMed ID: 30968145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.
    Okugawa Y; Toiyama Y; Ichikawa T; Kawamura M; Yasuda H; Fujikawa H; Saigusa S; Ohi M; Araki T; Tanaka K; Inoue Y; Tanaka M; Miki C; Kusunoki M
    Int J Oncol; 2018 Aug; 53(2):737-749. PubMed ID: 29767252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells.
    Kim NH; Cha YH; Kang SE; Lee Y; Lee I; Cha SY; Ryu JK; Na JM; Park C; Yoon HG; Park GJ; Yook JI; Kim HS
    Cell Cycle; 2013 May; 12(10):1578-87. PubMed ID: 23624843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative mechanisms of miR-34a regulation in cancer.
    Slabáková E; Culig Z; Remšík J; Souček K
    Cell Death Dis; 2017 Oct; 8(10):e3100. PubMed ID: 29022903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications.
    Tong X; Qiao S; Dong Z; Zhao X; Du X; Niu W
    J Nanobiotechnology; 2024 Jul; 22(1):409. PubMed ID: 38992688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis.
    Jiang L; Yang S; Yin H; Fan X; Wang S; Yao B; Pozzi A; Chen X; Harris RC; Zhang MZ
    Mol Cancer Res; 2013 Sep; 11(9):1040-50. PubMed ID: 23741059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
    Wei B; Huang QY; Huang SR; Mai W; Zhong XG
    Mol Med Rep; 2015 Oct; 12(4):5255-61. PubMed ID: 26238271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-34a/WNT7B modulates the sensitivity of cholangiocarcinoma cells to p53-mediated photodynamic therapy toxicity.
    Han Y; Yang Y; Huang S; Yao L; Wu L
    Biochem Biophys Res Commun; 2022 Feb; 591():54-61. PubMed ID: 34999254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53, miR-34a and EMP1-Newly Identified Targets of TFF3 Signaling in Y79 Retinoblastoma Cells.
    Busch M; Klein S; Große-Kreul J; Scheiner O; Metz K; Stephan H; Dünker N
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.